Publications

• Proposed Expansion of California Healthcare Transaction Oversight Takes Aim at Private Equity
  25 March 2025
  Andrew L. Bab
  ,
  Spencer K. Gilbert
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Mackenzie Mendolla
• California Legislature Again Seeks to Restrict Private Equity Investments in Healthcare
  28 February 2025
  Andrew L. Bab
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Mackenzie Mendolla
• MarketCheck – Winter 2025
  January 2025
  Andrew L. Bab
  ,
  Emily F. Huang
  ,
  Andrew G. Jamieson
  ,
  Stephen Jordan
  ,
  Jonathan E. Levitsky
  ,
  Gordon Moodie
  ,
  Daniel Priest
  ,
  William D. Regner
  ,
  Katherine Durnan Taylor
  ,
  Robert T. Dura
  ,
  Caitlin Gibson
  ,
  Stuart Hammer
  ,
  Sarah R. Jacobson
  ,
  Kim T. Le
  ,
  Weichi Liu
• Top 10 Healthcare and Life Sciences Issues to Watch in 2025
  10 January 2025
  Andrew L. Bab
  ,
  Tim Cornell
  ,
  Avi Gesser
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Erez Liebermann
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Jane Shvets
  ,
  Patrick Taylor
  ,
  Erica S. Weisgerber
  ,
  Carter Burwell
  ,
  Kim T. Le
  ,
  Leah Martin
  ,
  Melissa Runsten
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  HJ Brehmer
  ,
  Lillian Clark
  ,
  Zoe Jacoby
  ,
  Adriana Kranjac Rielly
  ,
  Chaim Lapp
  ,
  Hannah R. Levine
  ,
  Kaitlyn McGill
  ,
  Adam C. Saunders
  ,
  Abby Draper
  ,
  Mackenzie Mendolla
• Federal Trade Commission Finalizes Updates to the Health Breach Notification Rule
  20 May 2024
  Andrew L. Bab
  ,
  Avi Gesser
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Melissa Runsten
  ,
  Johanna N. Skrzypczyk
  ,
  Hannah R. Levine
  ,
  Kaitlyn McGill
  ,
  Annabella M. Waszkiewicz
• California Lawmakers Target Private Equity and Hedge Fund Investment in Healthcare Facilities
  23 February 2024
  Andrew L. Bab
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
• California’s Office of Health Care Affordability Finalizes Health Care Transaction Notice Regulations
  12 January 2024
  Andrew L. Bab
  ,
  Spencer K. Gilbert
  ,
  Kevin Rinker
  ,
  Matthew M. Delja
  ,
  Kim T. Le
  ,
  Hannah R. Levine
• Top 10 Healthcare and Life Sciences Issues to Watch in 2024
  4 January 2024
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Melissa Runsten
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Ilya Balabanovsky
  ,
  Margaret Howard
  ,
  Chaim Lapp
  ,
  Hannah R. Levine
  ,
  Zoe Jacoby
  ,
  Kaitlyn McGill
• CMS Announces First Ten Medicare Part D Drugs Subject to Price Negotiations
  6 October 2023
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
• California Regulators Publish Draft Regulations on Health Care Pre-Transaction Notice Requirements
  29 August 2023
  Andrew L. Bab
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
• California Seeks to Increase Healthcare Workers’ Minimum Wage to $25/hour
  21 August 2023
  Andrew L. Bab
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
• Artificial Intelligence in Healthcare: Balancing Risks and Rewards
  31 July 2023
  Andrew L. Bab
  ,
  Avi Gesser
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Tigist Kassahun
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Mengyi Xu
• FDA Guidance Offers Additional Clarity for Decentralized Clinical Trials
  30 May 2023
  Andrew L. Bab
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
• Legal Dispute Surrounding Abortion Pill Has Significant Implications for Broader Healthcare Industry
  9 May 2023
  Andrew L. Bab
  ,
  Maura Kathleen Monaghan
  ,
  Paul D. Rubin
  ,
  Shannon Rose Selden
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Melissa Runsten
• New York Seeks Review and Approval Authority over Certain Healthcare Transactions
  7 March 2023
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
• Proceed with Caution: Online Tracking Technologies Pose HIPAA Compliance Risks
  2 March 2023
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Hannah R. Levine
• Private Equity Report: 2023 Outlook
  January 2023
  Catherine Amirfar
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Jason Auerbach
  ,
  Dominic Blaxill
  ,
  Ezra Borut
  ,
  Kara Brockmeyer
  ,
  Geoffrey P. Burgess
  ,
  Lawrence K. Cagney
  ,
  Andrew J. Ceresney
  ,
  Alexander R. Cochran
  ,
  Eric Dinallo
  ,
  Christopher Dortschy
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Jyotin Hamid
  ,
  Ted Hassi
  ,
  Morgan J. Hayes
  ,
  Gareth Hughes
  ,
  Peter J. Irwin
  ,
  Mark Johnson
  ,
  Eric T. Juergens
  ,
  Rafael Kariyev
  ,
  Satish M. Kini
  ,
  M. Natasha Labovitz
  ,
  Henry Lebowitz
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Jonathan F. Lewis
  ,
  Marilyn A. Lion
  ,
  Timothy McIver
  ,
  John (Jay) Neukom
  ,
  Benjamin R. Pedersen
  ,
  Marc Ponchione
  ,
  Nicholas F. Potter
  ,
  Ryan T. Rafferty
  ,
  Julie M. Riewe
  ,
  Samantha J. Rowe
  ,
  Paul D. Rubin
  ,
  Scott B. Selinger
  ,
  Jane Shvets
  ,
  Steven J. Slutzky
  ,
  Patricia Volhard
  ,
  Erica S. Weisgerber
  ,
  Barbara N. Barath
  ,
  Alison E. Buckley-Serfass
  ,
  Zhiyan Cao
  ,
  Robert T. Dura
  ,
  Robert M. Fettman
  ,
  Andrew J. Gershon
  ,
  Jin-Hyuk Jang
  ,
  Stuart Hammer
  ,
  Kim T. Le
  ,
  Michael P. McGuigan
  ,
  Sheena Paul
  ,
  Tricia Bozyk Sherno
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Jeffrey P. Cunard
  ,
  Ulysses Smith
  ,
  Jennifer R. Cestaro
  ,
  Paul Eastham
  ,
  Isabel Espinosa de los Reyes
  ,
  Jay E. Evans
  ,
  Christopher Gossage
  ,
  Yiran Ji
  ,
  Samuel D. Krawiecz
  ,
  Chaim Lapp
  ,
  Stacy S. Lee
  ,
  Emily MacKay
  ,
  Ezra Newman
  ,
  Melissa Runsten
  ,
  Sergio Torres
  ,
  Tiffany Wu
  ,
  Emma Macfarlane
  ,
  Matthew Stromecki
  ,
  Massy Vainshtein
• Practising Law Institute: Privacy Law Answer Book
  23 January 2023
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Jyotin Hamid
  ,
  Satish M. Kini
  ,
  Henry Lebowitz
  ,
  Erez Liebermann
  ,
  Maura Kathleen Monaghan
  ,
  David A. O'Neil
  ,
  Jim Pastore
  ,
  David Sarratt
  ,
  Jeffrey P. Cunard
  ,
  Kim T. Le
  ,
  Tricia Bozyk Sherno
  ,
  Johanna N. Skrzypczyk
  ,
  Michael Bloom
  ,
  Fanny Gauthier
  ,
  Hannah R. Levine
  ,
  Linda Lin
  ,
  Kate Saba
  ,
  Noah L. Schwartz
  ,
  Mengyi Xu
• Top 15 Healthcare and Life Sciences Issues to Watch in 2023
  9 January 2023
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Elie J. Worenklein
  ,
  Samuel J. Allaman
  ,
  Adam Aukland-Peck
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Adam C. Saunders
  ,
  Adrian St. Francis
  ,
  Emily G. Dennan
  ,
  Micah A. Rubin
• Implications of the Inflation Reduction Act for Investors in Life Sciences Companies
  November 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
• Private Equity Report Fall 2022, Vol 22, No 3
  November 2022
  Andrew L. Bab
  ,
  Sally Bergmann Hardesty
  ,
  Michael Bolotin
  ,
  Erin Cleary
  ,
  Matthew Dickman
  ,
  Gregory V. Gooding
  ,
  Mark P. Goodman
  ,
  Gareth Hughes
  ,
  Mark Johnson
  ,
  Henry Lebowitz
  ,
  Maurizio Levi-Minzi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kevin M. Schmidt
  ,
  Scott B. Selinger
  ,
  Ramya S. Tiller
  ,
  Zhiyan Cao
  ,
  Kim T. Le
  ,
  Jin-Hyuk Jang
  ,
  Tigist Kassahun
  ,
  Hannah R. Levine
  ,
  Keith J. Slattery
  ,
  Sergio Torres
  ,
  Dominique Trudelle
  ,
  Hadel Alfagir
  ,
  David N. Simpser
• Dealmaking Implications of California’s New Healthcare Cost Monitoring Law
  19 August 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
• Recent SCOTUS Decisions Impacting Healthcare
  3 August 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
• FTC Sharpens Focus on Private Equity
  17 June 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Leah Martin
  ,
  Adam C. Saunders
• California Poised to Grant Attorney General Broad Approval Authority over Healthcare Transactions
  16 June 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Hannah R. Levine
• Texas Federal Judge Sides with Providers in “No Surprises Act” Ruling
  1 March 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Adriana Kranjac Rielly
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
• 2021/2022 Private Equity Year-End Review and Outlook
  January 2022
  Jonathan Adler
  ,
  Catherine Amirfar
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Andrew L. Bab
  ,
  Geoffrey P. Burgess
  ,
  Ezra Borut
  ,
  Andrew J. Ceresney
  ,
  Jeffrey P. Cunard
  ,
  Alexander R. Cochran
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Morgan J. Hayes
  ,
  Eric T. Juergens
  ,
  Maurizio Levi-Minzi
  ,
  Nicholas P. Pellicani
  ,
  Ryan T. Rafferty
  ,
  Julie M. Riewe
  ,
  Scott B. Selinger
  ,
  Marc Ponchione
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Richard Ward
  ,
  Christopher Dortschy
  ,
  Andrew J. Gershon
  ,
  Emily F. Huang
  ,
  Jennifer Wheater
  ,
  Dominic Blaxill
  ,
  Charles Cartiglia
  ,
  Robert T. Dura
  ,
  Matthew J. Sacco
  ,
  Sheng Shao
  ,
  Sergio Torres
  ,
  Paul Eastham
  ,
  Christopher Gossage
  ,
  Robert B. Kaplan
  ,
  Sheena Paul
  ,
  John Young
  ,
  Jin-Hyuk Jang
  ,
  Lukas Ott
  ,
  Andrew M. Levine
  ,
  Stuart Hammer
  ,
  Ulysses Smith
  ,
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Peter J. Irwin
  ,
  Ina C. Popova
  ,
  Samantha J. Rowe
  ,
  M. Natasha Labovitz
  ,
  Sidney P. Levinson
  ,
  Paul D. Rubin
  ,
  Eric Dinallo
  ,
  Marilyn A. Lion
  ,
  Jacob W. Stahl
  ,
  Nicholas F. Potter
  ,
  Kim T. Le
  ,
  Adam Aukland-Peck
  ,
  Melissa Runsten
  ,
  Matthew Mrozek
  ,
  Michael C. Godbe
  ,
  Christel Y. Tham
  ,
  Lisa Wang Lachowicz
  ,
  Yiran Ji
• CLS Blue Sky Blog: Debevoise & Plimpton Discusses New Privacy Legislation in the U.S.: The Patchwork Problem Grows
  26 July 2021
  CLS Blue Sky Blog
  Johanna N. Skrzypczyk
  ,
  Kim T. Le
  ,
  HJ Brehmer
• 2021 Private Equity Midyear Review and Outlook
  22 July 2021
  Jonathan Adler
  ,
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Andrew L. Bab
  ,
  Megan K. Bannigan
  ,
  Sally Bergmann Hardesty
  ,
  David H. Bernstein
  ,
  Paul S. Bird
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Matthew Dickman
  ,
  Christopher Dortschy
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Peter A. Furci
  ,
  Avi Gesser
  ,
  Jyotin Hamid
  ,
  Morgan J. Hayes
  ,
  Peter J. Irwin
  ,
  Rafael Kariyev
  ,
  M. Natasha Labovitz
  ,
  Maurizio Levi-Minzi
  ,
  Andrew M. Levine
  ,
  Sidney P. Levinson
  ,
  Jonathan F. Lewis
  ,
  Marc Ponchione
  ,
  Ryan T. Rafferty
  ,
  Paul D. Rubin
  ,
  Zachary H. Saltzman
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Steven J. Slutzky
  ,
  Ramya S. Tiller
  ,
  Richard Ward
  ,
  Patricia Volhard
  ,
  Franci J. Blassberg
  ,
  Jeffrey P. Cunard
  ,
  Andrew J. Gershon
  ,
  Stuart Hammer
  ,
  Jin-Hyuk Jang
  ,
  Kim T. Le
  ,
  Sheena Paul
  ,
  Tricia Bozyk Sherno
  ,
  Jacob W. Stahl
  ,
  Jennifer Wheater
  ,
  John Young
  ,
  Adam Aukland-Peck
  ,
  Dominic Blaxill
  ,
  Charles Cartiglia
  ,
  Robert T. Dura
  ,
  Paul Eastham
  ,
  Jay E. Evans
  ,
  David J. Hotelling
  ,
  Samuel D. Krawiecz
  ,
  Wen-Wei Lai
  ,
  Robert Maddox
  ,
  Sergio Torres
  ,
  Malina Welman
• The American Rescue Plan Act of 2021: Implications for Healthcare and Life Sciences Companies
  12 March 2021
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Benjamin Leb
• Proposed Elimination of Medicaid Rebate Cap Could Negatively Impact Innovator Pharmaceutical Industry
  11 February 2021
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Biden Takes Aim at Trump Administration Healthcare Policies
  2 February 2021
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• 2020/2021 Private Equity Year End Review and Outlook
  7 January 2021
  Jonathan Adler
  ,
  William D. Regner
  ,
  John W. Rife III
  ,
  Jennifer R. Cestaro
  ,
  Katherine Ashton
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Thomas Smith
  ,
  Ramya S. Tiller
  ,
  Christopher Anthony
  ,
  Kevin M. Schmidt
  ,
  Maurizio Levi-Minzi
  ,
  Geoffrey P. Burgess
  ,
  Dominic Blaxill
  ,
  Wen-Wei Lai
  ,
  Jyotin Hamid
  ,
  Morgan J. Hayes
  ,
  Steven J. Slutzky
  ,
  Richard Ward
  ,
  Jennifer Wheater
  ,
  Paul Eastham
  ,
  Peter A. Furci
  ,
  Rafael Kariyev
  ,
  Jay E. Evans
  ,
  Samuel D. Krawiecz
  ,
  Andrew L. Bab
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Jyotin Hamid
  ,
  Jonathan F. Lewis
  ,
  Tricia Bozyk Sherno
  ,
  Ezra Borut
  ,
  Jeffrey P. Cunard
  ,
  Marc Ponchione
  ,
  Kenneth J. Berman
  ,
  Patricia Volhard
  ,
  Christopher Dortschy
  ,
  Jin-Hyuk Jang
  ,
  John Young
  ,
  Andrew J. Ceresney
  ,
  Robert B. Kaplan
  ,
  Julie M. Riewe
  ,
  Sally Bergmann Hardesty
  ,
  Scott B. Selinger
  ,
  Stuart Hammer
  ,
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Jim Pastore
  ,
  Megan K. Bannigan
  ,
  David H. Bernstein
  ,
  M. Natasha Labovitz
  ,
  Sidney P. Levinson
  ,
  Peter J. Irwin
  ,
  Malina Welman
  ,
  Paul S. Bird
• Consolidated Appropriations Act: Implications for Healthcare and Life Sciences Companies
  30 December 2020
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kristin D. Kiehn
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• The Trump Administration’s Final Drug Pricing Hurrah—Will It Last?
  24 November 2020
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Federal Government Shines Spotlight on Speaker Programs
  20 November 2020
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Paul D. Rubin
  ,
  Kristin D. Kiehn
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• The Potential Impact of a Biden Administration on Life Sciences, Healthcare, and Consumer Product Companies and Investors
  2 November 2020
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Maura Kathleen Monaghan
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Providers, Investors Need Clear Post-COVID Telehealth Picture
  22 September 2020
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• Bloomberg Law: Providers, Investors Need Clear Post-Covid Telehealth Picture
  16 September 2020
  Bloomberg Law
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
  ,
  Kim T. Le
• Bloomberg Law: Providers, Investors Need Clear Post-Covid Telehealth Picture
  16 September 2020
  Bloomberg Law
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Melissa Runsten
  ,
  Kim T. Le
• Trump’s Newest Drug Pricing Executive Order: Still Much More Bark than Bite
  16 September 2020
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten
• HHS Announces Additional CARES Act Funding for Qualifying Providers
  4 August 2020
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Kim T. Le
  ,
  Melissa Runsten